2.905
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire
SG Americas Securities LLC Boosts Stock Position in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech's Crucial Full Year Earnings Reveal: Q4 Financial Results Coming February 27 - StockTitan
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 5, 2025 - BioSpace
Inside Puma Bio's Latest Executive Compensation Move: Key Details on RSU Grants - StockTitan
Millennium Management LLC Reduces Stake in Puma Biotechnology Inc - GuruFocus.com
JPMorgan Chase & Co. Acquires 30,499 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma commences Phase II trial of alisertib for breast cancer treatment - MSN
US Penny Stocks To Watch In January 2025 - Simply Wall St
Zacks Research Analysts Increase Earnings Estimates for PBYI - Defense World
What is Zacks Research's Forecast for PBYI FY2025 Earnings? - MarketBeat
Zacks Research Has Optimistic Outlook of PBYI Q4 Earnings - Defense World
Research Analysts Offer Predictions for PBYI Q4 Earnings - MarketBeat
Barclays PLC Increases Stake in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist? - Yahoo Finance
Jane Street Group LLC Buys 16,374 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Insufficient Growth At Puma Biotechnology, Inc. (NASDAQ:PBYI) Hampers Share Price - Simply Wall St
Zacks Research Has Negative Outlook of PBYI FY2024 Earnings - MarketBeat
Zacks Research Issues Pessimistic Estimate for PBYI Earnings - Defense World
FY2025 EPS Forecast for Puma Biotechnology Raised by Analyst - Defense World
FY2025 EPS Estimate for Puma Biotechnology Lifted by Analyst - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates - Yahoo Finance
Geode Capital Management LLC Has $2.34 Million Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Barclays PLC Buys 46,370 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
Best Value Stocks to Buy for January 6th - Yahoo Finance
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock By Investing.com - Investing.com Australia
Puma Biotechnology's SVP sells $27,208 in stock - Investing.com India
Puma Biotechnology chief commercial officer sells $29,742 in stock By Investing.com - Investing.com Australia
Puma Biotechnology chief commercial officer sells $29,742 in stock - Investing.com India
Puma Biotechnology, Inc. (NASDAQ:PBYI) Insider Jeffrey Jerome Ludwig Sells 9,437 Shares - MarketBeat
Alan H. Auerbach Sells 33,841 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock - MarketBeat
Puma Biotechnology's SVP sells $27,208 in stock By Investing.com - Investing.com South Africa
Puma Biotechnology’s SVP sells $27,208 in stock By Investing.com - Investing.com Nigeria
Puma Biotechnology CFO sells shares worth $32,232 By Investing.com - Investing.com Australia
Puma Biotechnology CFO sells shares worth $32,232 - Investing.com
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock - Investing.com
Franklin Resources Inc. Invests $41,000 in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology Grants RSU Awards to New Employees, Covering 24,375 Shares - StockTitan
State Street Corp Has $1.53 Million Stake in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - MSN
All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy - Yahoo Finance
Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN
Puma biotechnology sales earnings call - Ciudad Florida
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):